8 drug(s) with this reaction
3,928 total reports
Acute Kidney Injury has been reported as an adverse reaction across 8 drug(s) manufactured by Abbvie Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 3,928 adverse event reports mention acute kidney injury in connection with Abbvie Inc products.
This page provides a breakdown of which Abbvie Inc drugs are most commonly associated with acute kidney injury, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Abbvie Inc drugs have acute kidney injury listed in their FDA adverse event reports, sorted by report count:
In addition to acute kidney injury, the following adverse reactions have been reported across Abbvie Inc's drug portfolio:
8 drug(s) manufactured by Abbvie Inc have acute kidney injury listed in their FDA adverse event reports: FENOFIBRATE, RITONAVIR, VENETOCLAX, PANCRELIPASE, LOPINAVIR AND RITONAVIR, and others.
There are a combined 3,928 reports of acute kidney injury across 8 Abbvie Inc drug(s) in the FDA adverse event database.